2014
DOI: 10.1136/bcr-2013-200409
|View full text |Cite
|
Sign up to set email alerts
|

Collagenous enterocolitis and maturity onset type 1 diabetes manifesting as uraemia, malabsorption and extreme weight loss

Abstract: A 37-year-old patient with type 1 diabetes had been recently diagnosed with collagenous colitis (CC) after sigmoidoscopy. She rapidly progressed from a fortnight of watery diarrhoea, to a malabsorptive state with severe dehydration and acute kidney injury. This necessitated admission to an intensive care unit for emergency dialysis. She was subsequently diagnosed with collagenous enterocolitis affecting gastric, small bowel and colonic mucosa which required systemic steroid therapy. Physicians caring for patie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 36 publications
0
3
0
Order By: Relevance
“…Symptoms consist of chronic watery diarrhoea and a considerable number of patients suffer with abdominal pain, nocturnal symptoms and weight loss. Diarrhoea symptoms often follow a chronic relapsing and remitting course 4 5. Although a chronic disease, severe complications are infrequent, with only few cases of colonic perforations reported 6 7.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Symptoms consist of chronic watery diarrhoea and a considerable number of patients suffer with abdominal pain, nocturnal symptoms and weight loss. Diarrhoea symptoms often follow a chronic relapsing and remitting course 4 5. Although a chronic disease, severe complications are infrequent, with only few cases of colonic perforations reported 6 7.…”
Section: Discussionmentioning
confidence: 99%
“…This is likely explained by the predominant changes of collagenous colitis, which tends to affect the proximal colon, which is the main site of action of budesonide. There are no clinical trials examining the utility of budesonide for panenteric collagen deposition apart from collagenous colitis 4. Miehlke et al 5 in their multicentre, randomised controlled trial did demonstrate that budesonide had better clinical and histological remission rates than mesalazine and placebo at week 8.…”
Section: Discussionmentioning
confidence: 99%
“…Serological testing5 8 and human leucocyte antigen typing9 for CD may be positive in some cases of CS. GFD alone is usually ineffective for the treatment of CS, which often requires corticosteroids 1.…”
Section: Discussionmentioning
confidence: 99%